Skip to main content

Table 2 Types and management of antithrombotic agents in patients injected with epinephrine–saline (Group A) or hypertonic saline (Group B) for colorectal endoscopic mucosal resection (EMR)

From: Colorectal endoscopic mucosal resection with submucosal injection of epinephrine versus hypertonic saline in patients taking antithrombotic agents: propensity-score-matching analysis

 Group AGroup BP value
Number of antithrombotic agents
 Single agent88 (86.3%)85 (83.3%)0.70
 Multiple agents14 (13.7%)17 (16.7%) 
Anticoagulants21 (20.6%)40 (39.2%)0.006
 Warfarin12 (11.8%)25 (24.5%) 
 DOAC9 (8.8%)14 (13.7%) 
Management before EMR
 Cessation5 (5.0%)2 (2.0%)0.45
 Heparin replacement15 (14.7%)24 (23.5%)0.15
 DOAC replacement1 (1.0%)1 (1.0%)1.00
Antiplatelet agents85 (83.3%)69 (67.6%)0.014
 Aspirin36 (35.3%)40 (39.2%) 
 Clopidogrel20 (19.6%)12 (11.8%) 
 Ticlopidine6 (5.8%)1 (1.0%) 
 Cilostazol16 (15.7%)9 (8.8%) 
 Others7 (6.9%)7 (6.9%) 
Management before treatment
 Cessation4 (3.9%)3 (2.9%)1.00
 Cilostazol replacement15 (14.7%)11 (10.8%)0.53
  1. Results are presented as mean ± SD or number of patients. DOAC: direct oral anticoagulants